Benzinga | Aug 4, 2021 04:59PM EDT

Adaptive Biotechnologies Q2 EPS $(0.35) Beats $(0.42) Estimate, Sales $38.50M Beat $31.26M Estimate

Adaptive Biotechnologies (NASDAQ:ADPT) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.42) by 16.67 percent. This is a 34.62 percent decrease over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $38.50 million which beat the analyst consensus estimate of $31.26 million by 23.16 percent. This is a 83.44 percent increase over sales of $20.99 million the same period last year.